News

AstraZeneca’s Calquence plus chemoimmunotherapy approved in EU to treat adult patients with previously untreated mantle cell lymphoma: Cambridge, UK Wednesday, May 7, 2025, 09:0 ...
Cambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been ...
A 100,000-meter drill programme is currently underway at the Boundiali gold project, with a particular focus on the higher ...
West Red Lake Gold Mines Ltd. ("West Red Lake Gold" or "WRLG" or the "Company") is pleased to report positive reconciliation results from the bulk sample program at its 100% owned Madsen Mine located ...
Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...
Yari Minerals has diversified its Australian asset base to include the Rolleston South coal project, an advanced play with a ...
West Red Lake Gold Mines Ltd. ("West Red Lake Gold" or "WRLG" or the "Company") (TSXV: WRLG) (OTCQB: WRLGF) is pleased to report positive ...
Build your NBA parlay with smart alternate lines and player props for Tuesday’s playoff slate. See why these four legs offer ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2025 and updated financial ...